The News Herald (Willoughby, OH)

Vaccines must be held to highest standards of safety

- Keith Roach To Your Good Health Contact Dr. Roach at ToYourGood­Health@med. cornell.edu.

DEAR DR. ROACH » I read recently that a coronaviru­s vaccine is scheduled for release in late October or early November in the very early stages of clinical trials. Although the manufactur­er has offered assurances that the vaccine is safe, this seems awfully early. I understand that only one vaccine in history has been released this quickly, which was the anthrax vaccine.

I am 77 years old and reasonably healthy, but my age puts me in the higher risk category for contractin­g COVID-19. Would you recommend I get this vaccine as soon as it becomes available?

— P.L.

DEAR READER » I understand the desire for a vaccine quickly. An effective vaccine could dramatical­ly change the course of the pandemic, saving lives and allowing people to return to work sooner.

However, treatments that prevent disease must be held to the highest standards of safety. I recall the 1976 swine flu vaccine, which was associated with Guillain-Barre syndrome, although there remains controvers­y still about whether the swine flu vaccine really caused it or if it was a statistica­l fluke. I still have patients who refuse the flu vaccine due to that single event and the perception that it was a rushed and inadequate vaccine.

For me to recommend a vaccine, it must have undergone extensive evaluation, showing that its benefit far outweighs its risk. This requires a large number of volunteers and a significan­t follow-up period to identify any potential adverse effects. I have consistent­ly advised taking the currently recommende­d vaccines because of that thorough evaluation prior to approval and because of continued monitoring after release.

I am unaware of any vaccine that has the kind of record that would allow me to take or recommend it outside a clinical trial.

DEAR DR. ROACH » I would like to know why my vitamin D level is low and I have sarcoidosi­s of the skin from tattoos.

— Y.M.

DEAR READER » Sarcoidosi­s is a difficult disease to explain, since nobody really knows what causes it. It can affect every organ in the body — but especially the lungs and eyes — and can sometimes mysterious­ly disappear. The characteri­stic cell of sarcoid is the multinucle­ate giant cell, causing a granuloma, which is a collection of immune cells.

Tattoos can be affected by sarcoid, and occasional­ly are the first place that sarcoid starts. Red tattoo dye appears to be the most common trigger. Some people with tattoo sarcoid will then go on to develop lung or other body system sarcoid.

 ??  ??

Newspapers in English

Newspapers from United States